Evidence map›Paper›PMID 41745575›Full record

ReviewMetabolites2026

The "Immune Rebellion" from the Intestines to the Liver: A Vicious Cycle That Causes the Liver to Collapse.

Wan-Ting Wang, Jia-Le Tian, Shuo Gao, Mao-Bing Wang, Yang Luo, Xun Li

Abstract readReview
In one paragraph

Review in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wan-Ting WangThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Jia-Le TianThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Shuo GaoThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Mao-Bing WangThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Yang LuoThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.
Xun LiThe First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China.

Funding

Gansu Province Clinical Medical Research Center of General Surgery 20JR10FA661
6 · The paper itself

Abstract

The gut immune microenvironment and the liver engage in intricate information exchange via the gut-liver axis. The disruption of these interactions plays a pivotal role in the formation and exacerbation of pathological damage to the liver. The gut immune microenvironment is not an independent layer of the gut barrier; rather, it permeates and regulates all other barrier functions, serving as the core coordinator. Disruption of the immune microenvironment in the gut-liver axis drives progression across the full disease spectrum-from steatosis to hepatitis, fibrosis, and even liver cancer-through the continuous influx of immune-stimulatory signals that overwhelm the liver's intrinsic immune regulatory mechanisms. Dysfunction of innate immunity components, amplification of inflammatory factors and key cellular signaling pathways, activation of adaptive immune T cells, and systemic effects mediated by liver-derived inflammatory factors collectively form a disordered immune microenvironment. This damages the intestinal barrier and exacerbates liver disease via the gut-liver axis, leading to further intestinal injury, thus establishing a self-reinforcing vicious cycle. Current therapeutic strategies based on modulating the gut-liver axis microenvironment remain limited, yet studies have demonstrated that suppressing gut immune cells, cytokines, and signaling pathways can help delay liver disease progression. Hopefully, future combined, precise, and cutting-edge gut immunotherapies will provide more effective strategies for liver disease treatment.

Indexed as

gut barriergut immune microenvironmentgut–liver axisimmune dysregulationtherapeutic targets for liver disease

Identifiers

PMID41745575
PMCPMC12942146

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.